Dan Carestio

Dan Carestio serves as President and CEO of Steris, a global leader in infection prevention, sterilization, and surgical support solutions. Steris provides the essential equipment, consumables, and services that keep hospitals, surgical centers, pharmaceutical factories, and medical device manufacturers sterile and safe. Every surgical instrument must be sterilized between uses, every operating room must be decontaminated, and every pharmaceutical product must meet sterility requirements — Steris provides the systems to make this happen. Steris operates through four segments: Healthcare (sterilizers, washer-disinfectors, surgical tables, surgical lights, and instrument management systems for hospitals), Applied Sterilization Technologies (contract sterilization services — sterilizing medical devices for third-party manufacturers using ethylene oxide, gamma radiation, and electron beam technology), Life Sciences (sterilization and contamination control for pharmaceutical and biotech manufacturing), and Dental (infection prevention products for dental offices). The company's business is exceptionally resilient: sterilization is non-discretionary (hospitals cannot skip instrument sterilization regardless of budgets), generates high recurring revenue (consumables, service contracts, and contract sterilization), and benefits from increasing regulatory stringency around infection control. Key stock drivers include hospital capital spending, surgical procedure volumes, contract sterilization demand, pharmaceutical manufacturing activity, consumable pull-through rates, and the regulatory environment for sterilization standards.